Cargando…
The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review
Emerging evidence indicates that FHIT is a candidate tumor suppressor in many types of tumors including non-small-cell lung carcinoma (NSCLC). However, the prognostic value and correlation between FHIT hypermethylation and clinicopathological characteristics of NSCLC remains unclear. In this report,...
Autores principales: | Wu, Xiaoyu, Wu, Guannan, Yao, Xuequan, Hou, Gang, Jiang, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760666/ https://www.ncbi.nlm.nih.gov/pubmed/26929601 http://dx.doi.org/10.2147/DDDT.S85253 |
Ejemplares similares
-
The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review
por: Yan, Wei, et al.
Publicado: (2016) -
Clinicopathological and prognostic significance of CDH1 hypermethylation in hepatocellular carcinoma: a meta-analysis
por: Wu, Xiaoyu, et al.
Publicado: (2019) -
Clinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature review
por: Guo, Hao, et al.
Publicado: (2016) -
Association of FHIT expression and FHIT gene hypermethylation with liver cancer risk: a PRISMA-compliant meta-analysis
por: Zhang, Yaping, et al.
Publicado: (2017) -
The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review
por: Su, Yunshu, et al.
Publicado: (2015)